About LPC Pharmaceuticals Ltd:

LPC (Pharmaceuticals) Ltd operates retail pharmacy outlets together with a wholesaling-distribution from a newly acquired 40,000 square feet of custom built warehousing plus a 13,000 square feet standalone quarantine holding facility awaiting QC release. Retail operations play an important part in our overall business, allowing us easy access to market data, trading patterns, prescribing habits, government policies towards healthcare and customer demands. The wholesale-distribution business is primarily involved in the sale and supply of medicinal products (POM, P, GSL etc) to other pharmaceutical wholesalers & retailers.

LPC Medical (UK) Ltd owns the intellectual property (IP) a sizable portfolio of branded products. It is one of the groups asset holding companies. The company, after acquisition of Eastern Pharmaceuticals assets, owns some 160 licences, enabling the company to offer a comprehensive product range, including private label to the GSL sector and POM & P category of products to pharmacy sector. Besides our own licences, we have access to third party licences, thus allowing us to offer an extensive product range. Sourcing, acquisition and development of IP & products is an on-going activity, dependant on prevailing market conditions and opportunities.

Rusco Ltd is another of the group's asset holding company consisting of products under the category of GSL.

Chicago Labs is a joint venture established to acquire four patents from University of Illinois, USA, on an exclusive worldwide basis. This venture allows one to be near to an excellent teaching institution engaged in R&D in different field of medicines and opens up oppertunities for the group. The com